Skip to main content
. 2021 Feb 10;113(4):884–894. doi: 10.1093/ajcn/nqaa383

TABLE 4.

Effect of maternal nutritional supplementation during lactation on infant growth1

Measure  Unadjusted risk ratio or unadjusted mean difference (95% CI)  Adjusted risk ratio or adjusted mean difference (95% CI)2
Intervention (n = 408) Control (n = 408)
Attained anthropometric measures at 6 mo of infant age3
 Primary outcome
  LAZ at 6 mo (n = 388, 384) −0.89 ± 1.12 −1.0 ± 1.01 0.10 (−0.05, 0.25) 0.09 (−0.03, 0.20)
 Secondary outcomes
  WAZ at 6 mo (n = 388, 384) −1.08 ± 1.16 −1.17 ± 1.07 0.08 (−0.08, 0.24) 0.08 (−0.05, 0.21)
  WLZ at 6 mo (n = 388, 384) −0.63 ± 1.16 −0.66 ± 1.06 0.03 (−0.12, 0.19) 0.04 (−0.11, 0.20)
  Showed stunting at 6 mo (n = 388, 384) 59 (15.2) 58 (15.1) 1.00 (0.70,1.45) 1.09 (0.75,1.59)
  Showed wasting at 6 mo (n = 388, 384) 47 (12.1) 36 (9.4) 1.29 (0.84, 1.99) 1.29 (0.83, 1.99)
  Underweight at 6 mo (n = 388, 384) 73 (18.8) 77 (20.1) 0.94 (0.68, 1.29) 0.96 (0.70, 1.33)
  MUAC z score at 6 mo (n = 388, 384) −0.53 ± 1.06 −0.56 ± 0.99 0.03 (−0.12, 0.17) 0.03 (−0.11, 0.16)
  Head circumference z score at 6 mo in cm, (n = 388, 384) −1.39 ± 1.01 −1.45 ± 1.06 0.06 (−0.09, 0.20) 0.04 (−0.09, 0.17)
Change in anthropometric measures over the 6-mo period4
 Change in LAZ at 0–3 mo (n = 386, 367) 0.16 ± 0.72 0.15 ± 0.74 0.01 (−0.09, 0.11) 0.03 (−0.07, 0.12)
 Change in LAZ at 3–6 mo (n = 378, 361) 0.16 ± 0.66 0.11 ± 0.66 0.04 (−0.06, 0.14) 0.06 (−0.04, 0.16)
 Mean 3-monthly change in LAZ 0.03 (−0.04, 0.09) 0.04 (−0.02, 0.10)
 Change in WLZ at 0–3 mo (n = 358, 334) 0.48 ± 1.21 0.45 ± 1.38 0.03 (−0.13, 0.19) 0.04 (−0.10, 0.19)
 Change in WLZ at 3–6 mo (n = 378, 361) −0.18 ± 0.82 −0.14 ± 0.89 −0.03 (−0.19, 0.13) −0.05 (−0.19, 0.10)
 Mean 3-monthly change in WLZ 0.00 (−0.10, 0.10) 0.00 (−0.08, 0.08)
 Change in MUAC at 0–3 mo (n = 386, 367) 3.29 ± 1.07 3.24 ± 1.09 0.05 (−0.08,0.18) 0.06 (−0.07,0.19)
 Change in MUAC at 3–6 mo (n = 378, 361) 0.76 ± 0.74 0.80 ± 0.74 −0.05 (−0.18, 0.08) −0.04 (−0.17, 0.09)
 Mean 3-monthly change in MUAC 0.00 (−0.08,0.08) 0.01 (−0.07, 0.09)
1

Data are n (%) or mean ± SD, with outcome measures of adjusted risk ratios for the numbers of infants showing stunting, wasting, or underweight, and adjusted mean differences for other growth parameters. None of the P values (2-sided) were significant. BMI-Z, BMI z score; GEE, generalized estimating equation; GLM, generalized linear model; MUAC, midupper arm circumference; LAZ, length-for-age z score; WAZ, weight-for-age z score; WLZ, weight-for-length z score.

2

Adjusted for wealth quintile, gestational age, and LAZ and BMI-Z at baseline.

3

Analysis using GLM.

4

Analysis using GEE with Gaussian family, identity link, exchangeable correlation; adjusted for wealth quintile, BMI-Z at baseline, and gestational age for LAZ changes; adjusted for wealth quintile, LAZ scores, BMI-Z at baseline and gestational age for WLZ changes; adjusted for wealth quintile, LAZ, and BMI-Z at baseline and gestational age for MUAC changes.